Skip to main content

Table 1 Associations between vimentin/E-cadherin expression and other clinicopathological factors in pNETs

From: High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors

Variable Total, n Vimentin expression, n   E-cadherin expression, n  
Low High P Lost Preserved P
Age, years     0.205    0.908
  ≤ 60 156 122 34   80 76  
  > 60 71 50 21   37 34  
Sex     0.239    0.902
 Male 100 72 28   52 48  
 Female 127 100 27   65 62  
Symptoms     0.944    0.696
 Absent 94 71 23   47 47  
 Present 133 101 32   70 63  
Tumor size, cm     0.044    0.003
  ≤ 2 101 83 18   41 60  
  > 2 126 89 37   76 50  
Tumor location     0.344    0.578
 Head/uncinate/neck 103 75 28   51 52  
 Body/tail 124 97 27   66 58  
T-stage     0.538    0.026
 T1–2 180 138 42   86 94  
 T3–4 47 34 13   31 16  
LN metastasis     < 0.001    0.015
 Absent 203 161 42   99 104  
 Present 24 11 13   18 6  
Distant metastasis     0.002    0.022
 Absent 218 169 49   109 109  
 Present 9 3 6   8 1  
Perineural invasion     0.023    0.007
 Absent 204 159 45   99 105  
 Present 23 13 10   18 5  
WHO classification     0.010    < 0.001
 Grade 1 117 97 20   45 72  
 Grade 2 110 75 35   72 38  
AJCC stage     < 0.001    0.002
 I-II 193 156 37   91 102  
 III-IV 34 16 18   26 8  
  1. pNETs Pancreatic neuroendocrine tumors, LN Lymph node, AJCC American Joint Committee on Cancer
\